Metastatic Hormone Refractory Prostate Cancer Recruiting Phase 1 Trials for Fludeoxyglucose F-18 (DB09502)

Also known as: Metastatic hormone refractory Prostate cancer / Metastatic Prostate cancer / Prostate cancer metastatic / Metastatic Prostate Carcinoma / Carcinoma of the prostate metastatic / Prostatic cancer metastatic

IndicationStatusPhase
DBCOND0036371 (Metastatic Hormone Refractory Prostate Cancer)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02429804NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate CancerDiagnostic